Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
about
Atypical hemolytic uremic syndromeHemolytic uremic syndrome: new developments in pathogenesis and treatmentCharacterization of shark complement factor I gene(s): genomic analysis of a novel shark-specific sequenceAnalysis of binding sites on complement factor I that are required for its activityMembrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndromePathogenesis of thrombotic microangiopathiesGenetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeThe development of atypical hemolytic uremic syndrome depends on complement C5Genetic, molecular and functional analyses of complement factor I deficiencyMutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohortPredisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndromeGain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndromeMutations in complement C3 predispose to development of atypical hemolytic uremic syndromeSuccessful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population.Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.Excessive activation of the complement system in atypical hemolytic uremic syndrome: is it ready for prime time?Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.Thrombotic microangiopathies: multimers, metalloprotease, and beyond.Atypical hemolytic uremic syndrome in the Tunisian population.Genetics and complement in atypical HUS.aHUS caused by complement dysregulation: new therapies on the horizon.Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.Complement activation during liver transplantation-special emphasis on patients with atypical hemolytic uremic syndrome.Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndromeAge-related penetrance of hereditary atypical hemolytic uremic syndrome.Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?
P2860
Q21202864-8818E016-134B-4F31-BD40-A58F252D5B4DQ24613517-DA1B6C7F-06B3-4B3E-ADC1-48DF7341FA0AQ24642533-8654D75B-21F2-4C1E-9E0F-6CCF9849EF86Q24645042-B6F9D66C-87BC-475E-B242-49599ABE9BD5Q24650823-785CBE45-CDCB-4494-B155-2A24AA31973EQ24658043-94659A91-F8D8-4DB2-B30A-58EF8C5B780FQ24685473-73AEC517-A525-41CF-A274-AF0547EDF8EFQ28300378-124A2709-5CF9-42AF-9BA3-111559E8BB39Q28303343-CB5193DC-868A-4324-A98C-52B58DFB3B94Q28741729-DFE4EF6A-F239-4017-A6AD-72A5083F5111Q33364613-FE76E718-CFE7-4BEF-8152-816330117B67Q33372382-727008D3-40B3-48A5-9F81-FE37A11292B0Q33372850-741D7C8A-AD78-4539-B37B-3DC7A02151E1Q33372897-5F7EA217-6428-4DD8-B885-DEF470BEB992Q33373674-A2183479-B0CC-4766-8E8C-C7021809180EQ33375335-36C9DAF3-85E9-450F-894C-124D6C4C5DC8Q33377223-574A318E-DBA7-4E4A-B48D-222A121E7D8CQ33377727-42EE48DF-7CCF-4A41-AB99-3A0B1CC307F5Q33377799-C9FE5B8D-A694-4D96-AF1A-F1B1E0E76595Q33378236-11E9A850-01ED-4FA1-8873-FDF9BE3A315BQ33378469-9C4D2445-E1AD-4307-A2C3-E1FDBE3E2FF5Q33381182-886F294D-0085-4EC9-98AB-46D5BF3F18A1Q33381980-87BE3918-329E-4FF9-B15D-FD0D0C0A2314Q33382404-539EF017-A663-49AB-943F-19D98287F2C4Q33384039-B198B75F-EB61-4ECF-89B0-3940138DC7CCQ33385154-96A6784A-E645-4BB7-B795-D299C6188B51Q33385329-990750B8-EB75-47D5-8DBF-BBC936480C14Q33388046-9532A2EB-2C1A-441B-A040-F73A4CC6C973Q33388474-49392F52-188A-4D13-B0F3-7936AA11E32CQ33389435-4DCBE66D-D8C7-4A9A-9E03-13BDFF07D50FQ33389773-A180FA55-5A34-4D07-BFA3-C52B2A2B17B2Q33389945-5EE52D33-A1CC-4DF8-90CD-3DA1CB4C551AQ33390198-5DE2F1D1-F696-4ED1-81D2-916FB11B7453Q33392316-B2BBC83A-C957-48DB-8E70-9B6D9E8B53E0Q33395944-D5081390-03DD-4236-9CA7-816867025A98Q33396528-E54AE23E-FF4D-47E8-8A7D-4F99C65F3A6CQ33396792-3C1B3A89-F41E-4170-99B3-DCA3BA0EA9F5Q33397115-CABE9AFB-E2F7-4581-807E-F0AAC5F68B7AQ33398635-52C12708-D56B-4232-984E-11082E257654Q33399052-A502CF05-BBA6-4B11-8C36-F59F81889E8C
P2860
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
@ast
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
@en
type
label
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
@ast
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
@en
prefLabel
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
@ast
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
@en
P2093
P356
P1476
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
@en
P2093
B Boudailliez
V Fremeaux-Bacchi
P356
10.1136/JMG.2004.019083
P407
P577
2004-06-01T00:00:00Z